International uniform response criteria for multiple myelomaBrian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al.|Leukemia|2006Cited by 2.6k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONJoan Bladé, David H. Vesole, Diana Samson et al.|British Journal of Haematology|1998Cited by 1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D. Benson, Teresa Coelho, Márcia Waddington‐Cruz et al.|New England Journal of Medicine|2018Cited by 1.4k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisMorie A. Gertz, G Grateau, Ray Comenzo et al.|American Journal of Hematology|2005Cited by 1.4k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesGiovanni Palladini, Giampaolo Merlini, Angela Dispenzieri et al.|Journal of Clinical Oncology|2012Cited by 965